News

Results Found (492)
June 24, 2007
BioJerusalem Launches Activities

Jerusalem Development Authority allocates initial 10 million NIS to BioJerusalem

June 21, 2007
Yissum spin-off Mobileye - a warning system as your co-pilot

Reinventing the wheel- the latest car technology on the Wall Street Journal

June 6, 2007
Chilean president's first cousin shares prestigious HU young researcher award

A Hebrew University doctoral student who is the first cousin of the president of Chile has won a prestigious research prize for developing a "knockout technique" in special "antibody nose drops" against allergies that he tested successfully on...

May 24, 2007
Through the Glass Ceiling: Professional and positive- A profile of Nava...

Nava Swersky Sofer isn't the type of person to look back at her accomplishments and congratulate herself. Instead, she says, she's a forward thinker who focuses keenly on her next move. 

April 17, 2007
Yissum spin-off Tiltan knocks cancer to it knees (Hebrew article)

Tiltan attacks cancer using four different materials 

 

April 12, 2007
Yissum Subsidiary Collplant raises NIS 18.6m

The company has developed a method for applying transgenic tobacco to produce human recombinant collagen.

April 11, 2007
Yissum sells its Holdings in BioCancell Theraputics to Clal Biotechnology...

CBI will purchase 24% of the cancer-drug developer; Yissum keeps its royalties agreement

April 5, 2007
Yissum spin-off Novagali succeeds in Phase III clinical trials

Novagali Pharma Announces Positive Vekacia(R) Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis

 

April 4, 2007
The featherless broiler is ready to go to market

Four years after the first information on featherless broiler research was known, the attention of the public and world media was attracted. Commercial trials show the big advantage over their feathered relatives, especially when kept in tropical...

March 25, 2007
Yissum licenses a new anti-inflammatory technology to Bioline (Hebrew article)

Bioline will develop a new drug based on the technology of Prof. Hillel Bercovier and Dr. Ayelet Barenholz of the Hebrew university. 

 

February 28, 2007
Target-In to collaborate with US biotech co KaloBios

The agreement is reportedly worth several million dollars. 

 

January 30, 2007
New agreement signed between Target-In and Century Pharmaceuticals (Hebrew...

Yissum subsidiary Target-In and Indian company Century Pharmaceuticals will jointly develop a new drug for asthma and allergy, which will be based on the molecule developed by the Israel company.  

(Hebrew article attached)